GO:0045813 positive regulation of Wnt signaling pathway, calcium modulating pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045813 describes any process that increases the frequency, rate or extent of Wnt signaling in which activated receptors raise intracellular calcium and activate protein kinase C (PKC).
• This calcium-modulating branch is distinct from the canonical β-catenin-dependent Wnt pathway and is often referred to as the Wnt/Ca2+ or frizzled-2 signaling pathway.
• Key molecular players include Wnt ligands such as WNT-3a, frizzled receptors, G proteins, phospholipase C, inositol trisphosphate, calcium/calmodulin-dependent kinase II and PKC.
• The pathway intersects with β-catenin signaling in several contexts, including cancer, neuroinflammation, osteogenic transdifferentiation and stem cell differentiation [1,3,4,5,6].
• Dysregulation of Wnt/Ca2+ signaling has been implicated in colorectal cancer, glioblastoma, melanoma, ischemic stroke and vascular calcification [1,3,4,5,8].
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential for dissecting the causal roles of individual pathway components.
Description
GO:0045813, positive regulation of Wnt signaling pathway, calcium modulating pathway, is a biological process Gene Ontology term that captures the upregulation of a non-canonical Wnt signaling cascade. In this pathway, binding of a Wnt protein to a frizzled receptor on the target cell surface leads to an increase in intracellular calcium and activation of protein kinase C (PKC) [QuickGO definition]. This calcium-modulating branch is frequently called the Wnt/Ca2+ pathway and is distinct from the canonical β-catenin-dependent pathway. Researchers study GO:0045813 because it controls diverse cellular outcomes such as cell migration, differentiation, inflammation and tumorigenesis [1,3,4,5,6,8]. The importance of this term is underscored by its involvement in both normal physiology and disease. For example, WNT-3a alleviates neuroinflammation after ischemic stroke by modulating microglia/macrophages and astrocytes, while HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signaling. In colorectal cancer, phospholipase D6 activates Wnt/β-catenin signaling through mitochondrial metabolic reprogramming. These studies highlight that positive regulation of calcium-modulating Wnt signaling is not a single linear event but a network of intersecting signals. Understanding GO:0045813 requires integrating molecular mechanism, cellular context and disease relevance. This article provides a research-grade overview based on QuickGO annotation and verified PubMed literature, covering the core steps, key genes, experimental models and CRISPR strategies used to study this pathway.
positive regulation of Wnt signaling pathway, calcium modulating pathway At A Glance
| GO ID | GO:0045813 |
|---|---|
| GO term | positive regulation of Wnt signaling pathway, calcium modulating pathway |
| Ontology | biological_process |
| Synonym | activation of frizzled-2 signaling pathway; positive regulation of frizzled-2 signaling pathway; positive regulation of Wnt-activated signaling pathway, calcium modulating pathway; up regulation of frizzled-2 signaling pathway |
| Major function | Increases the frequency, rate or extent of Wnt signaling that raises intracellular calcium and activates PKC |
| Pathway type | Non-canonical Wnt/Ca2+ signaling |
| Key second messenger | Calcium (Ca2+) |
| Key effector | Protein kinase C (PKC) |
| Related receptor | Frizzled-2 (FZD2) and other frizzled family members |
What Is GO:0045813?
GO:0045813 is defined as any process that activates or increases the frequency, rate or extent of the series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell, where activated receptors lead to an increase in intracellular calcium and activation of protein kinase C (PKC). In simpler terms, it is the positive regulation of a Wnt signaling branch that uses calcium as a second messenger and PKC as a key effector. This term is a child of positive regulation of Wnt signaling pathway and is synonymous with activation of frizzled-2 signaling pathway, positive regulation of Wnt-activated signaling pathway, calcium modulating pathway, and related phrases.
Why Is positive regulation of Wnt signaling pathway, calcium modulating pathway Important in Cell Biology?
GO:0045813 is important because it defines a regulatory node that amplifies Wnt signals through calcium and PKC, influencing cell fate decisions, immune responses and tissue homeostasis. Dysregulation of this process contributes to cancer progression, neuroinflammation, vascular calcification and impaired differentiation [1,3,4,5,6,8]. Targeting positive regulators of this pathway may offer therapeutic opportunities, and understanding its mechanism is essential for interpreting experimental data in developmental biology and disease research.
• Controls non-canonical Wnt signaling that elevates intracellular calcium and activates PKC.
• Modulates neuroinflammation after ischemic stroke through microglia/macrophages and astrocytes.
• Promotes glioblastoma proliferation via activation of Wnt/β-catenin signaling.
• Activates Wnt/β-catenin signaling in colorectal cancer through phospholipase D6 and metabolic reprogramming.
• Regulates osteogenic transdifferentiation and calcification of vascular smooth muscle cells.
• Influences keratinocyte differentiation from human embryonic stem cells.
• Is implicated in melanoma development through circ_0084043/miR-429/TRB2 axis and Wnt/β-catenin pathway.
• Augments Nrf-2 and Wnt signaling in aged rats after NT-020 treatment.
• Provides a mechanism for crosstalk between calcium signaling and β-catenin-dependent transcription.
• Serves as a target for CRISPR-based functional studies of non-canonical Wnt components.
What Happens During positive regulation of Wnt signaling pathway, calcium modulating pathway?
Wnt ligand binding and receptor activation
In simple terms: A Wnt protein docks onto a frizzled receptor on the cell surface, switching the receptor on.
The pathway begins when a Wnt ligand, such as WNT-3a, binds to a frizzled family receptor on the target cell membrane. This interaction activates the receptor, which in the calcium-modulating branch leads to downstream events that increase intracellular calcium and activate PKC. Positive regulation of this step can occur through increased ligand availability, receptor upregulation or enhanced receptor sensitivity. Studies in ischemic stroke show that WNT-3a modulates microglia/macrophages and astrocytes, indicating that ligand-receptor engagement is a key control point.
G protein activation and phospholipase C signaling
In simple terms: The activated receptor turns on G proteins, which then activate an enzyme that makes calcium-releasing molecules.
Upon receptor activation, heterotrimeric G proteins are engaged, leading to activation of phospholipase C (PLC). PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers calcium release from intracellular stores, while DAG contributes to PKC activation. This step is a critical amplification point for the calcium-modulating Wnt pathway. In colorectal cancer, phospholipase D6 activates Wnt/β-catenin signaling through mitochondrial metabolic reprogramming, illustrating crosstalk between lipid signaling and Wnt pathways.
Intracellular calcium increase and PKC activation
In simple terms: Calcium levels rise inside the cell, which helps turn on protein kinase C.
The release of calcium from the endoplasmic reticulum and subsequent calcium influx raise cytosolic calcium concentration. Calcium binds to calmodulin and other calcium-sensing proteins, leading to activation of calcium/calmodulin-dependent kinase II (CaMKII) and protein kinase C (PKC). PKC then phosphorylates downstream targets that modulate gene expression, cell migration and differentiation. This calcium-PKC axis is the defining feature of GO:0045813. In glioblastoma, HPCAL1 promotes proliferation via activation of Wnt/β-catenin signaling, suggesting that calcium-binding proteins can intersect with this pathway.
Crosstalk with β-catenin-dependent transcription
In simple terms: The calcium branch can talk to the canonical Wnt pathway, affecting gene expression.
Although the calcium-modulating pathway is often described as non-canonical, it intersects with β-catenin signaling. For example, WNT/β-catenin signaling promotes osteogenic transdifferentiation and calcification of vascular smooth muscle cells through direct modulation of Runx2 gene expression. In melanoma, knockdown of circ_0084043 suppresses development through the miR-429/TRB2 axis and Wnt/β-catenin pathway. These findings indicate that positive regulation of the calcium-modulating pathway can influence canonical Wnt target genes, either directly or through shared components.
Feedback regulation and pathway termination
In simple terms: The cell has brakes to shut off the signal after it has done its job.
Positive regulation of Wnt/Ca2+ signaling is balanced by negative feedback mechanisms, including receptor internalization, degradation of second messengers and induction of inhibitory proteins. For instance, NT-020 treatment in aged rats augments Nrf-2 and Wnt signaling, suggesting that pharmacological interventions can modulate pathway activity. Understanding these feedback loops is essential for designing experiments that measure true positive regulation rather than transient fluctuations.
Key Genes Involved in GO:0045813 positive regulation of Wnt signaling pathway, calcium modulating pathway
The following genes and proteins are central to the positive regulation of the Wnt signaling pathway, calcium modulating pathway, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WNT3A | Wnt ligand that activates frizzled receptors | Alleviates neuroinflammation after ischemic stroke |
| FZD2 | Frizzled receptor for Wnt/Ca2+ signaling | Synonym for the pathway; mediates calcium release |
| PLD6 | Phospholipase D6, activates Wnt/β-catenin via metabolic reprogramming | Promotes tumorigenesis in colorectal cancer |
| HPCAL1 | Calcium-binding protein, promotes glioblastoma proliferation | Activates Wnt/β-catenin signaling |
| RUNX2 | Transcription factor downstream of Wnt/β-catenin | Mediates osteogenic transdifferentiation and calcification |
| PRKCA | Protein kinase C alpha, key effector of calcium signaling | Phosphorylates downstream targets in Wnt/Ca2+ pathway |
| CAMK2A | Calcium/calmodulin-dependent kinase II | Mediates calcium-dependent signaling in neurons and other cells |
| GNAQ | G protein alpha q, activates phospholipase C | Links receptor activation to calcium release |
| PLCB1 | Phospholipase C beta 1, produces IP3 and DAG | Generates calcium-mobilizing second messengers |
| ITPR1 | Inositol 1,4,5-trisphosphate receptor | Releases calcium from endoplasmic reticulum |
| NFATC1 | Nuclear factor of activated T cells, calcium-regulated | Couples calcium signaling to gene expression |
| CTNNB1 | β-catenin, canonical Wnt effector | Crosstalk with calcium-modulating pathway [5,8] |
| Nrf2 | Transcription factor, antioxidant response | Augmented with Wnt signaling in aged rats |
| TRB2 | Tribbles homolog 2, regulated by miR-429 | Involved in melanoma and Wnt/β-catenin pathway |
| circ_0084043 | Circular RNA, regulates miR-429/TRB2 axis | Suppresses melanoma development when knocked down |
| WNT5A | Non-canonical Wnt ligand | Often associated with calcium signaling |
| FZD7 | Frizzled receptor | Can activate non-canonical Wnt pathways |
| ROR2 | Receptor tyrosine kinase, non-canonical Wnt co-receptor | Modulates calcium-dependent Wnt signaling |
How Is positive regulation of Wnt signaling pathway, calcium modulating pathway Regulated?
The positive regulation of Wnt signaling pathway, calcium modulating pathway is controlled at multiple levels. Extracellularly, Wnt ligand availability and receptor expression determine signal initiation. Intracellularly, G protein activity, phospholipase C expression and calcium store content modulate the amplitude and duration of calcium release. PKC activity is regulated by phosphorylation, diacylglycerol and calcium. Crosstalk with other pathways, such as AMPK signaling, can influence cell responses; resveratrol affects cell activities and regulates AMPK signaling in pleural mesothelioma cells. Additionally, Nrf-2 and Wnt signaling are augmented in aged rats after NT-020 treatment, suggesting that redox and inflammatory status can modulate the pathway. Feedback mechanisms, including receptor desensitization and second messenger degradation, prevent excessive signaling.
positive regulation of Wnt signaling pathway, calcium modulating pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLD6 | Colorectal cancer | Knockout in HCT116 or SW480 cells; overexpression in normal colon cells |
| HPCAL1 | Glioblastoma | Knockdown or knockout in U87 or U251 cells; orthotopic mouse model |
| WNT3A | Ischemic stroke neuroinflammation | Overexpression in microglia/macrophages; middle cerebral artery occlusion model |
| RUNX2 | Vascular calcification | Point mutation in RUNX2 in vascular smooth muscle cells; calcification assays |
| circ_0084043 | Melanoma | Knockdown in A375 or SK-MEL-28 cells; xenograft mouse model |
Cancer
Dysregulation of calcium-modulating Wnt signaling is implicated in several cancers. In colorectal cancer, phospholipase D6 activates Wnt/β-catenin signaling through mitochondrial metabolic reprogramming to promote tumorigenesis. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signaling. In melanoma, knockdown of circ_0084043 suppresses development through the miR-429/TRB2 axis and Wnt/β-catenin pathway. These studies suggest that positive regulators of the calcium branch can drive oncogenic phenotypes.
Neuroinflammation and stroke
WNT-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes. This indicates that activation of Wnt signaling, potentially through calcium-modulating mechanisms, can have protective effects in the brain. NT-020 treatment reduces inflammation and augments Nrf-2 and Wnt signaling in aged rats, further supporting a role in neuroinflammation.
Vascular calcification and differentiation
WNT/β-catenin signaling promotes vascular smooth muscle cells to osteogenic transdifferentiation and calcification through direct modulation of Runx2 gene expression. This process may involve calcium-modulating components, as calcium is a key driver of osteogenic differentiation. Additionally, stagewise keratinocyte differentiation from human embryonic stem cells can be directed by defined signal transduction modulators, highlighting the role of Wnt pathways in differentiation.
From positive regulation of Wnt signaling pathway, calcium modulating pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PLD6 reduce Wnt/β-catenin signaling and tumor growth? | PLD6 knockout in colorectal cancer cell lines (e.g., HCT116) and xenograft |
| Does HPCAL1 promote glioblastoma proliferation via Wnt/β-catenin? | HPCAL1 knockout or knockdown in glioblastoma cells; proliferation and invasion assays |
| Can WNT3A alleviate neuroinflammation after stroke? | WNT3A overexpression in microglia/macrophages; middle cerebral artery occlusion in mice |
| Does RUNX2 point mutation affect osteogenic transdifferentiation? | Knock-in of mutant RUNX2 in vascular smooth muscle cells; calcification assays |
| Does circ_0084043 knockdown suppress melanoma via miR-429/TRB2? | CRISPR knockout of circ_0084043 in melanoma cells; xenograft |
| Does overexpression of calcium-modulating Wnt components alter PKC activity? | Overexpression of FZD2, GNAQ or PLCB1 in HEK293 or cancer cells; PKC activity assays |
How to Study the positive regulation of Wnt signaling pathway, calcium modulating pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging | Intracellular calcium concentration | Live-cell imaging after Wnt ligand stimulation |
| PKC activity assay | Phosphorylation of PKC substrates | In vitro kinase assays or phospho-specific Western blot |
| RNA-seq | Global gene expression changes | Identifying downstream targets of pathway activation |
| Proteomics | Protein abundance and modifications | Detecting crosstalk and feedback regulation |
| CRISPR knockout screen | Loss-of-function effects on pathway activity | Discovering novel positive regulators |
| CRISPR activation screen | Gain-of-function effects on pathway activity | Identifying genes that enhance signaling |
| Xenograft models | Tumor growth and metastasis | Testing role of candidate genes in cancer |
| Immunofluorescence | Subcellular localization of pathway components | Visualizing receptor internalization and calcium stores |
Calcium imaging and PKC activity assays
To measure positive regulation of the calcium-modulating Wnt pathway, researchers use fluorescent calcium indicators (e.g., Fluo-4, Fura-2) to monitor intracellular calcium changes upon Wnt ligand stimulation. PKC activity can be assessed by phosphorylation-specific antibodies or kinase assays. These methods directly test the defining features of GO:0045813.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can identify genes and proteins whose expression changes when the pathway is activated or inhibited. For example, studies in colorectal cancer used metabolic reprogramming analysis to link PLD6 to Wnt/β-catenin signaling. Such approaches reveal downstream targets and crosstalk networks.
CRISPR-based functional screens
Genome-wide CRISPR knockout or activation screens can identify positive regulators of the calcium-modulating Wnt pathway. Cells expressing a calcium-responsive reporter or PKC-dependent reporter can be sorted to enrich for modifiers. This unbiased approach can uncover novel components beyond known genes.
In vivo disease models
Animal models such as ischemic stroke, glioblastoma xenografts and vascular calcification models are used to study the pathway in a physiological context [3,4,5]. These models allow assessment of therapeutic potential and validation of in vitro findings.
How CRISPR Can Be Used to Study GO:0045813 positive regulation of Wnt signaling pathway, calcium modulating pathway
Knockout
CRISPR knockout is used to delete genes encoding components of the calcium-modulating Wnt pathway, such as FZD2, GNAQ, PLCB1 or PLD6. Knockout cell lines can reveal whether a candidate gene is required for Wnt-induced calcium release and PKC activation. For example, PLD6 knockout in colorectal cancer cells would test its role in Wnt/β-catenin signaling and tumorigenesis.
Point Mutation
Point mutations can be introduced to mimic activating or inactivating mutations in pathway genes. For instance, mutating phosphorylation sites in PKC or calcium-binding residues in HPCAL1 can dissect their functional importance. Point-mutation models are valuable for understanding structure-function relationships.
Knock-in
Knock-in of reporter genes, such as fluorescent calcium indicators or PKC activity reporters, allows real-time monitoring of pathway activity. Tagged knock-in of endogenous genes (e.g., GFP-FZD2) enables visualization of receptor trafficking. These models are powerful for dynamic studies.
Overexpression
Overexpression of Wnt ligands (e.g., WNT3A) or receptors (e.g., FZD2) can activate the pathway and test sufficiency. For example, WNT3A overexpression in microglia/macrophages was used to study neuroinflammation after stroke. Overexpression models complement loss-of-function approaches.
How EDITGENE Supports positive regulation of Wnt signaling pathway, calcium modulating pathway Research
Researchers studying positive regulation of Wnt signaling pathway, calcium modulating pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activation, calcium release or PKC-dependent phenotypes. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of Wnt signaling pathway, calcium modulating pathway research.
Frequently Asked Questions About positive regulation of Wnt signaling pathway, calcium modulating pathway
What is GO:0045813?
GO:0045813 is a Gene Ontology biological process term for positive regulation of Wnt signaling pathway, calcium modulating pathway. It describes processes that increase Wnt signaling that raises intracellular calcium and activates protein kinase C (PKC).
What genes are involved in positive regulation of Wnt signaling pathway, calcium modulating pathway?
Key genes include WNT3A, FZD2, PLD6, HPCAL1, RUNX2, PRKCA, CAMK2A, GNAQ, PLCB1 and ITPR1, among others [1,3,4,5].
How is the Wnt/Ca2+ pathway different from canonical Wnt signaling?
The Wnt/Ca2+ pathway elevates intracellular calcium and activates PKC, whereas canonical Wnt signaling stabilizes β-catenin to regulate transcription. Crosstalk exists between the two [5,8].
What diseases are associated with GO:0045813?
It has been implicated in colorectal cancer, glioblastoma, melanoma, ischemic stroke neuroinflammation and vascular calcification [1,3,4,5,8].
What experimental models are used to study this pathway?
Common models include CRISPR knockout cell lines, overexpression models, calcium imaging, PKC activity assays and in vivo disease models [1,3,4,5].
How can CRISPR help study positive regulation of Wnt signaling pathway, calcium modulating pathway?
CRISPR knockout, point mutation, knock-in and overexpression allow precise manipulation of pathway genes to test causality and mechanism.
What is the role of PKC in GO:0045813?
PKC is a key effector activated downstream of calcium release, and it phosphorylates targets that mediate cellular responses.
Which Wnt ligand is commonly used to activate the calcium-modulating pathway?
WNT-3a is frequently used and has been shown to alleviate neuroinflammation after ischemic stroke.
Can the calcium-modulating Wnt pathway be targeted therapeutically?
Modulating this pathway may have therapeutic potential in cancer, neuroinflammation and vascular calcification, but further research is needed [1,3,4,5].
What methods measure calcium release in this pathway?
Fluorescent calcium indicators such as Fluo-4 and Fura-2 are commonly used for live-cell imaging of intracellular calcium changes.
Conclusion
GO:0045813, positive regulation of Wnt signaling pathway, calcium modulating pathway, represents a critical non-canonical Wnt branch that controls calcium release and PKC activation. Its roles in cancer, neuroinflammation and differentiation make it a compelling research focus. By combining QuickGO annotation with verified literature, this article provides a framework for understanding its mechanism, key genes and experimental approaches. CRISPR-based models are indispensable for dissecting the causal roles of individual components. EDITGENE offers a full suite of services to support such studies, from knockout and point mutation to library screening and bioinformatics.
References
- 1. Lee HJ et al.. 2025. Phospholipase D6 activates Wnt/β-catenin signaling through mitochondrial metabolic reprogramming to promote tumorigenesis in colorectal cancer.. Exp Mol Med 57(4):910-924 PMID: 40259095
- 2. Iaquinta MR et al.. 2025. Resveratrol Affects Cell Activities, Induces Apoptosis and Regulates AMPK Signaling Pathway in Pleural Mesothelioma Cells.. FASEB J 39(20):e71120 PMID: 41110101
- 3. Zhang D et al.. 2019. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.. J Cell Mol Med 23(5):3108-3117 PMID: 30843345
- 4. Zhang D et al.. 2019. Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes.. Int Immunopharmacol 75:105760 PMID: 31323530
- 5. Cai T et al.. 2016. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.. Exp Cell Res 345(2):206-17 PMID: 27321958
- 6. Zhong H et al.. 2020. Stagewise keratinocyte differentiation from human embryonic stem cells by defined signal transduction modulators.. Int J Biol Sci 16(8):1450-1462 PMID: 32210732
- 7. Flowers A et al.. 2015. NT-020 treatment reduces inflammation and augments Nrf-2 and Wnt signaling in aged rats.. J Neuroinflammation 12:174 PMID: 26376629
- 8. Chen Z et al.. 2020. Knockdown of circ_0084043 suppresses the development of human melanoma cells through miR-429/tribbles homolog 2 axis and Wnt/β-catenin pathway.. Life Sci 243:117323 PMID: 31954160
